Science Magazine published #UTSW findings on nanoparticles created to repair the gene causing cystic fibrosis (CF) by replacing it with a healthy one. Discover how this breakthrough may offer hope for patients with genetic lung conditions. bit.ly/3L2xFpF #sciencetwitter

Chinese innovative drug R&D trends in 2024 bit.ly/3ykX8YK This new article analyses trends for the innovative drug candidates in the pipelines of Chinese companies

Breathing new life into in vivo lung editing New lipid nanoparticle designs make targeted in vivo lung editing possible in mice and may lead to new treatment options for cystic fibrosis go.nature.com/4cz7Rxu

Dan Daniel Siegwart delivered a plenary talk at North American Cystic Fibrosis Conference (NACFC2024) Cystic Fibrosis Foundation on Challenges and Progress in the Pursuit of Genetic Therapies for Cystic Fibrosis. Check it out on YouTube ⬇️ youtu.be/XBE5zVKNEUQ?si…

Congratulations, Victor Ambros UMass Chan Medical School and Gary Ruvkun Harvard Medical School!!! What a day for RNA!

Congratulations to Dan!

Thank you NIBIB for highlighting our work!

Siegwart lab is presenting at Biomedical Engineering Society 2024 Annual meeting by Ys Amogh and our alum Xizhen Lian 🎙️ Also come find us at Booth #426 to learn more about BME Department/Program at UTSouthwestern UTSW BME Grad Program UT Southwestern Biomedical Engineering Daniel Siegwart

Implementation of intellectual property education in academic institutions can result in increased opportunities for protecting IP and limit costs, but to be successful technology transfer offices must also adapt go.nature.com/4iCtdhc rdcu.be/d3sq8

Excited to share our new paper in Nature Materials 🔔 led by Yufen Xiao Daniel Siegwart Read the full story here: nature.com/articles/s4156…

Exclusive: NIH to terminate hundreds of active research grants nature.com/articles/d4158…

It’s a real honor to receive this prestigious scholarship award from Keystone Symposia and share my work under the guidance from Daniel Siegwart with the leader in the field #KSGenome25

Throwing it back today to celebrate Ys, @GDEatUTSW Graduate Student Researcher, for earning a scholarship award to attend Keystone Symposia's Precision Genome Engineering meeting in March. Yehui gave a talk on the lab's most recent publication in Science. #ThrowbackThursday

Dual SORT LNPs for multi-organ base editing go.nature.com/3HC9EHt

Our lab’s latest publication in Nature Biotechnology led by Minjeong Kim and Daniel Siegwart. Read the full story here: nature.com/articles/s4158…

Research Briefing: Delivering base editors to the liver and lungs in alpha-1 antitrypsin deficiency go.nature.com/43CWjYg

Advancing Multi-Organ Gene Editing We’re excited to announce that Dr. Minjeong Kim and the team have developed a revolutionary gene-editing system capable of targeting livers and lungs simultaneously. Check out our feature in @UTSWNews: utsouthwestern.edu/newsroom/artic…

It was an honor to be inducted into the National Academy of Inventors (NAI) ⁦⁦National Academy of Inventors⁩ tonight!

Daniel J. Siegwart on Development of selective organ targeting (SORT) lipid nanoparticles (LNPs) for genome correction of disease causing mutations #RNATx2025

Imagine treating a genetic disease affecting the lungs and liver with a single treatment. UTSW scientists are working to make this a reality. Discover how their innovative gene-editing delivery system could one day transform treatment options. bit.ly/3G4oWEy #GeneTherapy